GUTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

FRACTYL HEALTH, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$1.38−0.17 (-10.97%)

Close on Oct 19, 2026

Market cap: $218.94M
P/E (TTM): –
Dividend yield: –

FRACTYL HEALTH, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Cash & Equivalents	82	72	38	54
Cash & Short-Term Investments	82	72	38	54
Receivables	–	0	0.02	–
Inventory	–	0.07	0.07	–
Prepaid Expenses & Other	6.04	–	–	–
Total Current Assets	88	72	36	–
Property, Plant & Equipment	2.41	2.98	0.49	–
Gross Property, Plant & Equipment	5.13	4.57	5.32	–
Accumulated Depreciation	-2.72	-1.60	-4.83	–
Operating Lease Right-of-Use Assets	27	28	30	–
Other Long-Term Assets	0.34	0.67	5.54	–
Total Assets	121	108	76	–
Accounts Payable	1.57	3.24	0.55	–
Current Portion of Leases	5.10	4.96	2.73	–
Total Current Liabilities	18	20	11	–
Long-Term Debt	31	30	55	–
Long-Term Leases	26	27	29	–
Operating Lease Liabilities	31	32	31	–
Other Long-Term Liabilities	0.66	1.00	–	–
Total Liabilities	112	80	114	–
Total Debt	31	30	55	–
Preferred Stock	0	0	0	–
Common Stock	0.00	0	0	–
Additional Paid-In Capital	566	444	22	–
Retained Earnings	-556	-415	-347	–
Shareholders' Equity	9.46	28	-325	-252
Total Equity	9.46	28	-325	-252
Total Liabilities & Equity	121	108	76	–
Shares Outstanding(shares)	153	49	2.11	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -744.2%

Financial strength

Current ratio: 3.15
Debt to equity: -18.29
Debt to assets: 37.1%
Cash to current liabilities: 299.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –